The solid progress of nanomedicine

Show full item record



Permalink

http://hdl.handle.net/10138/317999

Citation

Martins , J P , das Neves , J , de la Fuente , M , Celia , C , Florindo , H , Günday-Türeli , N , Popat , A , Luis Santos , J , Sousa , F , Schmid , R , Wolfram , J , Sarmento , B & Santos , H A 2020 , ' The solid progress of nanomedicine ' , Drug Delivery and Translational Research , vol. 10 , no. 3 , pp. 726–729 . https://doi.org/10.1007/s13346-020-00743-2

Title: The solid progress of nanomedicine
Author: Martins, João Pedro; das Neves, José; de la Fuente, María; Celia, Christian; Florindo, Helena; Günday-Türeli, Nazende; Popat, Amirali; Luis Santos, José; Sousa, Flávia; Schmid, Ruth; Wolfram, Joy; Sarmento, Bruno; Santos, Hélder A.
Contributor: University of Helsinki, Nanomedicines and Biomedical Engineering
University of Helsinki, Helsinki One Health (HOH)
Date: 2020-06
Language: eng
Number of pages: 4
Belongs to series: Drug Delivery and Translational Research
ISSN: 2190-393X
URI: http://hdl.handle.net/10138/317999
Abstract: This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.
Subject: CANCER
CHEMOTHERAPY
Cancer therapy
Clinical translation
Nanomedicine
Nanotechnology
PACLITAXEL
Reproducibility
THERAPY
TUMOR
3122 Cancers
221 Nano-technology
317 Pharmacy
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
The_solid_progress_of_nanomedicine.pdf 252.4Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record